Media Call: Tobacco Product Standards – 4/29/2021

Medical Device Quality Management System Regulation Risk Management

FDA Expert Panel on Testosterone Replacement Therapy for Men

VIRTUAL PRESS CONFERENCE: FDA’s Proposed Rule on Reducing Nicotine Levels – 1/15/2025

FDA Grand Rounds - Antibody Glycosylation Insights for High Quality Biotherapeutics

Media Call: Second COVID-19 Vaccine – 12/18/2020

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

FDA-USP-AAM | D1S3 - Industry’s Engagement in USP’s Standards-Setting Process

January 22, 2026: Tobacco Products Scientific Advisory Committee Meeting

FDA Grand Rounds - Advancing Real World Evidence in FDA Regulatory Decision Making

FDA Grand Rounds - Anti biofilm Technologies for Enhancing the Safety of Medical Device Surfaces

Medical Device Quality Management System Regulation Design and Development

Public Meeting: Reauthorization of the Biosimilar User Fee Act

FDA Grand Rounds - Forensic Proteomics Applied to FDA Regulated Products

FDA Grand Rounds - Adopting Large Language Models for Regulatory Review

FDA Grand Rounds - Statistical Considerations for Drug Development in Rare Disease

FDA-USP-AAM | D1S4 – Q&A Discussion Panel

FDA Celebrates 120 Years

FDA Grand Rounds - Postmarket Regulation of Cosmetic Products: The Who, What, When, Why, and How

FDA-USP-AAM | D1S1 – FDA's Participation in USP-NF Revision Process – Challenges and Solutions

2025 FDA Achievements